NCT07123220Completed
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
Identification of Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus. A Multicenter Cross-sectional Cohort Study
Source: ClinicalTrials.gov · Last updated 13 Feb 2026
Brief summary (registry, in English)
Introduction: Fatigue is a well-established symptom in systemic lupus erythematosus. Depression and anxiety can develop at different stages of systemic lupus erythematosus and their severity can range from mild symptoms to more serious disorders. Patients with systemic lupus erythematosus may consider fatigue to be a symptom that is more severe than pain, depression, or anxiety. Objectives: To describe fatigue in patients with systemic lupus erythematosus and identify the best predictive model for fatigue in these patients. Methods: Multicenter cross-sectional cohort studies. Eighty-eight patients with systemic lupus erythematosus from different regions of Spain will be included in the studies. The primary variable will be fatigue (Fatigue Assessment Scale), with anxiety (State-Trait Anxiety Inventory) as the dependent variable. The secondary variables will be perceived quality of life (Lupus Quality of Life and 36-Item Short Form Survey Instrument), level of physical activity (International Physical Activity Questionnaire), and the main clinical, sociodemographic, and anthropometric variables. Expected results: To describe fatigue in patients with systemic lupus erythematosus, as well as the predictive model for fatigue in these patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 884 (actual)
- First submitted
- 7 Aug 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 13 Nov 2025
- Lead sponsor
- Investigación en Hemofilia y Fisioterapia
- Diseases
- Lupus (SLE)
- NCT number
- NCT07123220
What you commit to
- Study type: Observational
- Participants enrolled: 884
- From 1 Sept 2025 to the primary completion date, 13 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are receiving an intervention (physiotherapy or orthopedic) at the time of the study.
Other
- Patients with neurological or cognitive impairments that prevent them from understanding the questionnaires and physical tests.
Who the study is looking for
- Patients diagnosed with systemic lupus erythematosus.
- Over 18 years of age.
- Who have not had any flare-ups in the last 6 months.
- Who sign the informed consent form.
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidad de Oviedo Coordinator of this site? Confirm its status | Almería | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.